NSC |
Compound |
Enrichment |
Correlation |
NSC 119915 |
3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid |
0.0147237897640499 |
0.19616532 |
NSC 275647 |
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- |
0.0147237897640499 |
0.47755679 |
NSC 303861 |
L-Cysteine analog |
0.0147237897640499 |
0.57993676 |
NSC 328477 |
3'-Chloro-3-nitro-o-salicylotoluidide |
0.0147237897640499 |
0.58824545 |
NSC 335995 |
Null |
0.0147237897640499 |
0.3592165 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
0.0147237897640499 |
0.31478201 |
NSC 363813 |
Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- |
0.0147237897640499 |
0.3723997 |
NSC 624657 |
ANTINEOPLASTIC-624657 |
0.0147237897640499 |
0.2039585 |
NSC 633963 |
N,N'-Di{1-methyl-2-[1-methyl-2-carboxamido(3-propionamidine) -4-pyrrole]-4-pyrrolyl}suberamide dihydrochloride |
0.0147237897640499 |
0.30748909 |
NSC 637505 |
Null |
0.0147237897640499 |
0.49906446 |